BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21146215)

  • 1. Significantly reduced regulatory T cell population in patients with untreated multiple myeloma.
    Gupta R; Ganeshan P; Hakim M; Verma R; Sharma A; Kumar L
    Leuk Res; 2011 Jul; 35(7):874-8. PubMed ID: 21146215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma.
    Herth I; Witzens-Harig M; Beckhove P; Hose D; Meissner T; Neuber B; Engelhardt M; Haas J; Neben K; Ho AD; Klein B; Goldschmidt H; Hundemer M
    Exp Hematol; 2013 Mar; 41(3):231-40. PubMed ID: 23142220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.
    Feyler S; von Lilienfeld-Toal M; Jarmin S; Marles L; Rawstron A; Ashcroft AJ; Owen RG; Selby PJ; Cook G
    Br J Haematol; 2009 Mar; 144(5):686-95. PubMed ID: 19133978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide.
    Giannopoulos K; Schmitt M; Własiuk P; Chen J; Bojarska-Junak A; Kowal M; Roliñski J; Dmoszyñska A
    Leukemia; 2008 Jan; 22(1):222-4. PubMed ID: 17657216
    [No Abstract]   [Full Text] [Related]  

  • 5. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
    Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy.
    Moes N; Rieux-Laucat F; Begue B; Verdier J; Neven B; Patey N; Torgerson TT; Picard C; Stolzenberg MC; Ruemmele C; Rings EH; Casanova JL; Piloquet H; Biver A; Breton A; Ochs HD; Hermine O; Fischer A; Goulet O; Cerf-Bensussan N; Ruemmele FM
    Gastroenterology; 2010 Sep; 139(3):770-8. PubMed ID: 20537998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of thalidomide on CD4(+)CD25(+) T regulatory cells in patients with multiple myeloma].
    Yang Y; Zhang WG; He AL; Yang HY; Wang JL; Tian W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):538-42. PubMed ID: 18549624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
    Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [OKT-8+ suppressor T-lymphocytes are increased in patients with stable multiple myeloma].
    Ludwig C; Hicks MJ; Pena D; Durie BG
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1451-4. PubMed ID: 6227989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma.
    Dmoszynska A; Podhorecka M; Manko J; Bojarska-Junak A; Rolinski J; Skomra D
    Neoplasma; 2005; 52(2):175-81. PubMed ID: 15800717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis.
    Brandt C; Pavlovic V; Radbruch A; Worm M; Baumgrass R
    Allergy; 2009 Nov; 64(11):1588-96. PubMed ID: 19432936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
    Chi LJ; Wang HB; Zhang Y; Wang WZ
    J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The frequency and function of FoxP3+ regulatory T cell in patients with acute hepatitis B].
    Qin CX; Gao HW; Zhang Y; Gao L; Jia F; Zou YH; Yang XQ; Cuo XQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):1029-31. PubMed ID: 20104679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity.
    Prado C; Gómez J; López P; de Paz B; Gutiérrez C; Suárez A
    Immunobiology; 2011 Mar; 216(3):386-92. PubMed ID: 20667622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
    Namdar A; Nikbin B; Ghabaee M; Bayati A; Izad M
    J Neuroimmunol; 2010 Jan; 218(1-2):120-4. PubMed ID: 19932513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.